UK Earnings, Trading Statements Calendar | |
Wednesday, October 22 | |
City of London Investment Group | Interim Management Statement |
Senior | Interim Management Statement |
Development Securities | Half Year Results |
Petropavlovsk | Q3 Production Update |
Spirit Pub Company | Full Year Results |
British American Tobacco | Interim Management Statement |
Computacenter | Interim Management Statement |
GlaxoSmithKline | Q3 Results |
Home Retail Group | Half Year Results |
International Personal Finance | Interim Management Statement |
Laird | Interim Management Statement |
Playtech | Interim Management Statement |
Thursday, October 23 | |
Phoenix Group Holdings | Interim Management Statement |
Volution Group | Full Year Results |
Mountview Estates | Full Year Results |
Tesco | Half Year Results |
Ladbrokes | Interim Management Statement |
Mecom Group | Interim Management Statement |
Britivic | Interim Management Statement |
Anglo American | Q3 Production Report |
Anglo Platinum | Q3 Production Report |
Foreign & Colonial Investment Trust | Interim Management Statement |
Bloomsbury Publishing | Half Year Results |
Inchcape | Interim Management Statement |
Segro | Interim Management Statement |
St James's Place | Interim Management Statement |
Stobart Group | Half Year Results |
Unilever | Trading Statement |
SVG Capital | Interim Management Statement |
African Barrick Gold | Q3 Results |
Colt Group | Interim Management Statement |
National Express Group | Interim Management Statement |
Premier Foods | Interim Management Statement |
Reed Elsevier | Interim Management Statement |
Photo-Me International | Trading Statement |
Friday, October 24 | |
Dechra Pharmaceuticals | Interim Management Statement |
Shire | Q3 Results |
Vesuvius | Interim Management Statement |
Spectris | Interim Management Statement |
TSB Banking Group | Interim Management Statement |
Monday, October 27 | |
No Events Scheduled | |
Tuesday, October 28 | |
UBM | Interim Management Statement |
BP | Q3 Results |
Lloyds Banking Group | Interim Management Statement |
BG Group | Q3 Results |
Utilitywise | Full Year Results |
Copyright 2014 Alliance News Limited. All Rights Reserved. | |
Zantac not a cause of woman’s cancer, jury says in first trial over drug
CHICAGO, May 23 (Reuters) - A jury in Chicago on Thursday rejected an Illinois woman’s claim that the now discontinued heartburn drug Zantac caused her colon cancer, in the first trial out of thousands of lawsuits making similar allegations.
Read more